Analyst Price Targets — FOCL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 25, 2026 11:00 am | Swayampakula Ramakanth | H.C. Wainwright | $10.00 | $4.18 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on FocalTherics (FOCL) |
| August 14, 2026 12:20 pm | Jason Bednar | Piper Sandler | $4.00 | $4.66 | TheFly | FocalTherics price target raised to $4 from $3 at Piper Sandler |
| July 17, 2026 9:46 am | Anthony Petrone | Mizuho Securities | $15.00 | $5.44 | TheFly | FocalTherics initiated with an Outperform at Mizuho |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for FOCL

FocalTherics ™ to Present at the H.C. Wain w right 28 th Annual Global Investment Conference Company to Present and Host 1x1 Investor Meetings on T uesday and Wednesday, September 15 th -16 th , 2026 AUSTIN, Texas, Sept.

FocalTherics (NASDAQ: FOCL - Get Free Report) has earned a consensus recommendation of "Hold" from the five analysts that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell rating, two have given a hold rating, one has given a buy rating and one has issued a strong buy rating

EDAP TMS S.A. (FOCL) Q2 2026 Earnings Call Transcript

FocalTherics NASDAQ: FOCL reported second-quarter HIFU revenue of $13.2 million, up 39% from $9.5 million a year earlier, as the company continued to expand sales of its Focal One high-intensity focused ultrasound platform for focal therapy.

FocalTherics™ Reports Second Quarter 2026 Financial Results 39% Revenue Increase and 47% Growth in U.S. Procedures AUSTIN, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) -- FocalTherics™ (Nasdaq: FOCL) (the “Company”), a global leader in robotic focal therapy, today announced financial results for the second quarter of 2026. This marks the Company's first reporting period presenting its HIFU business as continuing operations…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for FOCL.
U.S. House Trading
No House trades found for FOCL.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
